|
Higher expression in G1 (GR, STM, and STD) |
| M.30 (75 genes) |
IRE1-mediated unfolded protein response |
4×10–4
|
4 |
|
| M.32 (236 genes) |
Hormone-mediated signaling pathway |
9×10–3
|
11 |
CARM1, WBP2, ZBTB7A
|
| M.7 (308 genes) |
Negative regulation of nucleobase-containing compound metabolic process |
6×10–4
|
51 |
CREBBP, DAB2IP, FOXK2, LARP1, RXRA, THRA
|
| Chromatin organization |
1×10–2
|
27 |
ARID1B, CREBBP, HUWE1
|
| M.17 (176 genes) |
Chromatin modifying enzymes |
4×10–3
|
11 |
HCFC1, SETD1A
|
|
Higher expression in G2 (RF, VL, and VM) and G3 (GL) |
| M.31 (945 genes) |
RNA splicing |
6×10–5
|
54 |
SNRNP70
|
| Histone modification |
3×10–3
|
47 |
KAT2A
|
| M.33 (538 genes) |
Apical junction complex |
2.4×10–2
|
11 |
MICALL2
|
| M.13 (300 genes) |
Mitochondrion |
4×10–45
|
122 |
AIFM1, ATP5F1A, ATP5F1B, CKMT2, COQ9, DLD, DLST, FH, GHITM, HADHA, HADHB, IMMT, MFN2, NDUFS2, PDHA1, PDHB, TRAP1, UQCRC2
|
| M.14 (162 genes) |
Anterior/posterior pattern specification |
4×10–3
|
7 |
HOXA11
|
|
Higher expression in G3 (GL) |
| M.5 (190 genes) |
Regulation of lipid metabolic process |
8×10–4
|
15 |
ADIPOQ, ADRA2A, CIDEA, LEP, LGALS12, PDE3B, SCD
|
| M.25 (188 genes) |
Ameboidal-type cell migration |
5×10–3
|
15 |
CFL1, PML, TGFB1
|
| Positive regulation of muscle cell differentiation |
9×10–3
|
6 |
EHD2, ENG, NIBAN2, TGFB1
|
| M.11 (299 genes) |
Golgi membrane |
2×10–3
|
30 |
ASAP2, MAN1A1
|
| Regulation of nervous system development |
8×10–3
|
30 |
IQGAP1
|
